Drawing for AGUETTANT

USPTO serial 97697395

AGUETTANT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
SABAGH, LAILA TAREK
Law office
TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AGUETTANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brooks R. Bruneau

Brooks R. Bruneau FISHERBROYLES, LLP100 OVERLOOK CENTERSECOND FLOORPRINCETON, NJ 08540

Goods and services

ClassDescriptionStatusFirst use
005Medical devices in the nature of delivery systems for pharmaceutical products, namely, prefilled syringes, injection pens and injectable administration devices, containing pharmaceutical preparations for the treatment of transitional bradycardia, hypotension, Parkinson's disease, hypersensitivity, asthmatic attacks, hypocalcemia, edema including as an adjunctive therapy for acute pulmonary edema, nephrotic syndroms, magnesium deficiency, cardiac arrest and transitory atrioventricular heart block or the prevention of cardiac arrest and transitory atrioventricular heart block, ventricular arrhythmias, and including as an adjuvant in surgical anaesthesia, and for prevention and control of pre-eclampsia and eclampsia seizuresACTIVE
042Research and Development services for new products in the fields of medical, pharmaceutical and/or biotechnologyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 9, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 9, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 10, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Nov 10, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 10, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 1, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2023DOCKASSIGNED TO EXAMINER
Feb 6, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 6, 2023ALIEASSIGNED TO LIE
Dec 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED
Dec 3, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance